Neurodegenerative diseases-Caps: a capsule network based early screening system for the classification of neurodegenerative diseases

被引:0
|
作者
Kirti Raj Bhatele
Anand Jha
Kavish Kapoor
Devanshu Tiwari
机构
[1] RJIT,
[2] BSF Academy,undefined
[3] Kavlabs,undefined
[4] RGPV,undefined
来源
Cognitive Neurodynamics | 2022年 / 16卷
关键词
Neurodegenerative diseases; Parkinson; Alzheimer; Capsule network; ResNet50; VGG 16; VGG 19; InceptionV3 etc.;
D O I
暂无
中图分类号
学科分类号
摘要
The two most generally diagnosed Neurodegenerative diseases are the Alzheimer and Parkinson diseases. So this paper presents a fully automated early screening system based on the Capsule network for the classification of these two Neurodegenerative diseases. In this study, we hypothesized that the Neurodegenerative diseases-Caps system based on the Capsule network architecture accurately performs the multiclass i.e. three class classification into either the Alzheimer class or Parkinson class or Healthy control and delivers better results in comparison other deep transfer learning models. The real motivation behind choosing the capsule network architecture is its more resilient nature towards the affine transformations as well as rotational & translational invariance, which commonly persists in the medical image datasets. Apart from this, the capsule networks overcomes the pooling layers related deficiencies from which conventional CNNs are mostly affected and unable to delivers accurate results especially in the tasks related to image classification. The various Computer aided systems based on machine learning for the classification of brain tumors and other types of cancers are already available. Whereas for the classification of Neurodegenerative diseases, the amount of research done is very limited and the number of persons suffering from this type of diseases are increasing especially in developing countries like India, China etc. So there is a need to develop an early screening system for the correct multiclass classification into Alzheimer’s, Parkinson’s and Normal or Healthy control cases. The Alzheimer disease and Parkinson progression (ADPP) dataset is used in this research study for the training of the proposed Neurodegenerative diseases-Caps system. This ADPP dataset is developed with the aid of both the Parkinson's Progression Markers Initiative (PPMI) and Alzheimer’s disease Neuroimaging Initiative (ADNI) databases. There is no such early screening system exist yet, which can perform the accurate classification of these two Neurodegenerative diseases. For the sake of genuine comparison, other popular deep transfer learning models like VGG19, VGG16, ResNet50 and InceptionV3 are implemented and also trained over the same ADPP dataset. The proposed Neurodegenerative diseases-Caps system deliver accuracies of 97.81, 98, 96.81% for the Alzheimer, Parkinson and Healthy control or Normal cases with 70/30 (training/validation split) and performs way better as compare to the other popular Deep transfer learning models.
引用
收藏
页码:1361 / 1377
页数:16
相关论文
共 50 条
  • [41] Drosophila as a screening tool to study human neurodegenerative diseases
    Lenz, Sarah
    Karsten, Peter
    Schulz, Joerg B.
    Voigt, Aaron
    JOURNAL OF NEUROCHEMISTRY, 2013, 127 (04) : 453 - 460
  • [42] Tensor Decomposition of Foot Pressure for Classification of Neurodegenerative Diseases
    Thapliyal, Devashish
    Pandey, Bhaskar
    Singh, Ramandeep
    Joshi, Deepak
    IEEE SENSORS LETTERS, 2024, 8 (05) : 1 - 4
  • [43] Biomarker-guided classification scheme of neurodegenerative diseases
    Baldacci, Filippo
    Lista, Simone
    Garaci, Francesco
    Bonuccelli, Ubaldo
    Toschi, Nicola
    Hampel, Harald
    JOURNAL OF SPORT AND HEALTH SCIENCE, 2016, 5 (04) : 383 - 387
  • [44] A movement monitoring system for patients of neurodegenerative diseases
    Gugliandolo, G.
    Sciva, A.
    Campobello, G.
    Capra, P. P.
    Marino, S.
    Bramanti, A.
    Di Lorenzo, G.
    Bramanti, P.
    Donato, N.
    2018 IEEE INTERNATIONAL INSTRUMENTATION AND MEASUREMENT TECHNOLOGY CONFERENCE (I2MTC): DISCOVERING NEW HORIZONS IN INSTRUMENTATION AND MEASUREMENT, 2018, : 1159 - 1164
  • [45] Neurophysiological diagnostics of the transcallosal system in Neurodegenerative diseases
    Wittstock, M.
    Benecke, R.
    KLINISCHE NEUROPHYSIOLOGIE, 2008, 39 (01) : 1 - 9
  • [46] The endocannabinoid system in targeting inflammatory neurodegenerative diseases
    Centonze, Diego
    Finazzi-Agro, Alessandro
    Bernardi, Giorgio
    Maccarrone, Mauro
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (04) : 180 - 187
  • [47] Probing the cholinergic system to understand neurodegenerative diseases
    Renard, Pierre-Yves
    Jean, Ludovic
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (02) : 131 - 133
  • [48] Nutritional Strategies in neurodegenerative Diseases of the motor System
    Lorenz, Judith
    AKTUELLE ERNAHRUNGSMEDIZIN, 2020, 45 (06):
  • [49] How the immune system shapes neurodegenerative diseases
    Mason, Hannah D.
    McGavern, Dorian B.
    TRENDS IN NEUROSCIENCES, 2022, 45 (10) : 733 - 748
  • [50] Aging visual system in the context of neurodegenerative diseases
    Boehm, M. R. R.
    OPHTHALMOLOGE, 2017, 114 (02): : 96 - 97